BioCryst Pharmaceuticals
BCRX
#4706
Rank
A$2.44 B
Marketcap
$11.81
Share price
1.43%
Change (1 day)
50.02%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of June 2024 : A$1.24 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is A$1.24 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$1.21 B11.16%
2022-12-31A$1.08 B33.15%
2021-12-31A$0.81 B125.11%
2020-12-31A$0.36 B200.64%
2019-12-31A$0.12 B37.78%
2018-12-31A$87.75 M25.2%
2017-12-31A$70.09 M-5.95%
2016-12-31A$74.53 M79.91%
2015-12-31A$41.42 M13.01%
2014-12-31A$36.65 M8.99%
2013-12-31A$33.63 M16.5%
2012-12-31A$28.86 M-1.33%
2011-12-31A$29.25 M
2000-12-31A$0.01 M
1997-12-31A$0.15 M-59.36%
1996-12-31A$0.37 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$1.12 B-9.59%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.08 B 66.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.27 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.35 B-71.61%๐Ÿ‡บ๐Ÿ‡ธ USA
A$35.45 B 2,741.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.62 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
A$32.63 B 2,515.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$1.30 B 4.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$18.42 M-98.52%๐Ÿ‡บ๐Ÿ‡ธ USA